Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy

Area of Science:

• Oncology
• Immunology
• Biomaterials Science

Background:

• Cancer immunotherapy shows promise but faces challenges with unpredictable outcomes and low response rates.
• Novel targeting delivery systems and modulators are crucial for broader patient and cancer type applicability.
• Extracellular vesicles (EVs) present a novel biomaterial for targeted, site-specific immunomodulation in cancer therapy.

Purpose of the Study:

• To review the molecular mechanisms of EV targeting specificity and immunomodulation.
• To highlight the unique properties of EVs as a platform for precision cancer immunotherapy.
• To discuss novel engineering strategies and challenges for EV-based cancer immunotherapeutics.

Main Methods:

• Review of preclinical and clinical studies on extracellular vesicles in cancer immunotherapy.
• Analysis of molecular understanding of EV cargos and surface receptors.
• Examination of EV properties including surface markers, intravesicular contents, and in vivo behavior.

Main Results:

• EVs offer targeted delivery and site-specific immune modulation, improving cancer immunotherapy efficacy.
• Understanding EV molecular components enhances cell targeting specificity and immunogenicity modulation.
• EVs demonstrate unique properties suitable for precision cancer immunotherapy applications.

Conclusions:

• Extracellular vesicles represent a powerful biomaterial for advancing cancer immunotherapy.
• Molecular engineering of EVs can reprogram and direct cancer immunotherapeutics effectively.
• EVs hold significant future potential for developing more effective and precise cancer treatments.